Effective January 2, 2024, the Board of Directors of Immunome, Inc., upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed  Carol Schafer as a Class I director of the Company, with a term of office expiring at the 2024 annual meeting of stockholders. Additionally, Ms. Schafer  has been appointed as a member and Chair of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board, in each case, effective as of the Appointment Date. In connection with Ms. Schafer?s appointment to the Audit Committee and the Nominating Committee, each of?James Boylan and Jean-Jacques Bienaimé stepped down as a?member of the Audit Committee and the Nominating Committee, respectively.

The Audit Committee is now composed of Ms. Schafer (Chair), Isaac Barchas, and Mr. Bienaimé, and the Nominating Committee is now composed of Mr. Barchas (Chair), Mr. Boylan, and Ms. Schafer. Ms. Schafer has more than 25 years of experience in investment banking and equity capital markets and has served as a corporate director for multiple public companies. Ms. Schafer currently serves as the Managing Partner of Hyphen Advisors.

Additionally, Ms. Schafer currently serves on the Board of Directors of Insmed, Repare Therapeutics and Kura Oncology, and previously served on the Board of Directors of Five Prime Therapeutics and Idera Pharmaceuticals. Prior to Hyphen Advisors, Ms. Schafer served as Vice Chair of Wells Fargo Securities, where she led the healthcare equity capital markets team and was responsible for originating and executing equity and convertible financings. Prior to joining Wells Fargo Securities, Ms. Schafer served as Vice President of Finance and Business Development of Lexicon Pharmaceuticals.

Previously, Ms. Schafer served as Managing Director, Equity Capital Markets of JPMorgan Chase working with companies in healthcare, retail, consumer and chemical industries. Ms. Schafer earned her MBA from New York University, and her BA in mathematics and computer science from Boston College.